Medcolcanna Organics Inc (TSE:MCCN)
CNQX:MCCN
Canadian Market
Holding TSE:MCCN?
Track your performance easily

Medcolcanna Organics Inc (MCCN) Financial Statements

0 Followers

Medcolcanna Organics Inc Financial Overview

Medcolcanna Organics Inc's market cap is currently ―. The company's EPS TTM is C$; its P/E ratio is ―; Medcolcanna Organics Inc is scheduled to report earnings on June 5, 2023, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 21Jun 21Mar 21Dec 20Sep 20
Income Statement-
Total RevenueC$ 156.39KC$ 103.16KC$ 46.07KC$ 10.99KC$ 51.99K
Gross ProfitC$ -94.97KC$ -311.42KC$ -231.06KC$ -991.67KC$ 55.19K
EBITC$ -1.92MC$ 794.68KC$ -1.43MC$ -3.21MC$ -1.35M
EBITDAC$ -896.01KC$ 717.02KC$ -1.30MC$ -3.28MC$ -1.25M
Net Income Common StockholdersC$ -2.13MC$ 584.11KC$ -1.57MC$ -3.24MC$ -1.40M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 114.67KC$ 67.78KC$ 125.17KC$ 276.76KC$ 1.03M
Total AssetsC$ 4.45MC$ 5.45MC$ 5.79MC$ 6.20MC$ 7.54M
Total DebtC$ 4.03MC$ 3.70MC$ 3.62MC$ 3.00MC$ 2.38M
Net DebtC$ 3.91MC$ 3.63MC$ 3.50MC$ 2.72MC$ 1.35M
Total LiabilitiesC$ 7.52MC$ 6.28MC$ 7.46MC$ 6.94MC$ 3.84M
Stockholders EquityC$ -2.94MC$ -716.82KC$ -1.57MC$ -654.09KC$ 3.75M
Cash Flow-
Free Cash FlowC$ -366.04KC$ -61.32KC$ -597.17KC$ -997.74KC$ -273.41K
Operating Cash FlowC$ -366.04KC$ -61.32KC$ -597.17KC$ -997.74KC$ -273.41K
Investing Cash FlowC$ -12.50KC$ 70.75KC$ -158.99KC$ -248.35KC$ -1.57M
Financing Cash FlowC$ 407.34KC$ 169.84KC$ 475.04KC$ 530.66KC$ 2.53M
Currency in CAD

Medcolcanna Organics Inc Earnings and Revenue History

Medcolcanna Organics Inc Debt to Assets

Medcolcanna Organics Inc Cash Flow

Medcolcanna Organics Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis